Postgraduate Program in Nursing, Federal University of Pelotas, Rio Grande do Sul, Brazil.
Postgraduate Program in Health Sciences, Federal University of Rio Grande, Rio Grande do Sul, Brazil.
J Affect Disord. 2022 Dec 1;318:272-282. doi: 10.1016/j.jad.2022.09.003. Epub 2022 Sep 10.
Uncertainty, disruptions in daily routines, and concerns for the health and well-being during the COVID-19 pandemic are likely associated with increases in generalized anxiety. The present study aimed to systematically review the literature in order to identify the update prevalence of anxiety in the general population during the COVID-19 pandemic.
A systematic review and meta-analysis. It included studies that assessed the prevalence of anxiety among the general population during the COVID-19 pandemic.
In total, we included 194 studies. The general prevalence of anxiety was 35.1 %, affecting approximately 851,000 participants. The prevalence in low and middle-income countries (35.1 %; 95%CI: 29.5 % to 41.0 %) was similar compared to high-income countries (34.7 %; 95%CI: 29.6 % to 40.1 %). In studies that provided the proportion of cases in each level of anxiety disorder, mild-to-moderate anxiety affected one quarter of the participants. One in ten cases with anxiety during the COVID-19 may be living with severe or extremely anxiety disorder. Most instruments estimated similar prevalence of anxiety disorders with notable difference in the prevalence estimated by the Generalized Anxiety Disorder 2-item (GAD-2), Zung Self-Rating Anxiety Scale (SAS), and State-Trait Anxiety Inventory (STAI).
One in three adults were living with anxiety disorder during the COVID-19 pandemic worldwide.
在 COVID-19 大流行期间，不确定性、日常生活的中断以及对健康和福祉的担忧，可能与广泛性焦虑症的增加有关。本研究旨在系统地回顾文献，以确定 COVID-19 大流行期间普通人群中焦虑症的最新患病率。
系统综述和荟萃分析。它包括评估 COVID-19 大流行期间普通人群中焦虑症患病率的研究。
共纳入 194 项研究。普通人群中焦虑症的总体患病率为 35.1%，影响了约 851000 名参与者。中低收入国家（35.1%；95%CI：29.5%至 41.0%）的患病率与高收入国家（34.7%；95%CI：29.6%至 40.1%）相似。在提供每种焦虑障碍病例比例的研究中，轻度至中度焦虑影响了四分之一的参与者。每 10 例 COVID-19 期间的焦虑症患者中，就有 1 例可能患有严重或极度焦虑症。大多数工具估计的焦虑症患病率相似，但通用焦虑症量表 2 项（GAD-2）、zung 自评焦虑量表（SAS）和状态特质焦虑量表（STAI）估计的患病率存在显著差异。
在 COVID-19 大流行期间，全世界每三个成年人中就有一个患有焦虑症。
